Can-Fite BioPharma Ltd.
AN A3 ADENOSINE RECEPTOR LIGAND FOR USE FOR ACHIEVING A FAT LOSS EFFECT
Last updated:
Abstract:
Provided is an A3 adenosine receptor (A.sub.3AR) ligand for use in achieving at least one fat loss effect selected from: reducing weight of the subject; reducing body fat mass in the subject; treating obesity in the subject and inhibiting adipocytes proliferation in a subject. The disclosure also concerns pharmaceutical compositions, methods of treatment and kits comprising the A.sub.3AR ligand.
Status:
Application
Type:
Utility
Filling date:
5 Jan 2020
Issue date:
17 Mar 2022